A closer look at pharma's top R&D budgets

from The Top Line · host Fierce Life Sciences

In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.  Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out! To learn more about the topics in this episode:  The top 10 pharma R&D budgets for 2024  This week's episode is brought to you by Cencora.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Apr 4, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

A closer look at pharma's top R&D budgets

0:00 11:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Top Line?

This episode is 11 minutes long.

When was this The Top Line episode published?

This episode was published on April 4, 2025.

Can I download this The Top Line episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!